Skip to the page content
Your donations
Passes our checks

The Gog Foundation Inc

EIN 03-0466352 · Edgewater, MD

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong90 out of 100GovernanceGood70 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES.

Income
$68.5 million
Spending
$65.1 million
Spent on programs
100%
Reserves
18 months of spending
Largest source of income
fees for its services, 88%
Employees
67
Volunteers
4
Highest pay
$383,376, chief financial officer

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 90 out of 100. Higher than 77% of charities in its peer group (medical research, $10m to $100m).

  • Reserves

    35 of 35

    Spendable reserves would cover 18.0 months of spending.

  • Debt

    10 of 20

    It owes 33% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 5% of income.

  • Income trend

    15 of 15

    Income rose 4% on the year before.

  • Spending floor

    15 of 15

    100% of spending went to programs and raising each dollar of donations cost 3 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Good: 70 out of 100. Higher than 7% of charities in its peer group (medical research, $10m to $100m).

  • Independent board

    5 of 25

    6 of 17 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $64.9 million spent. THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2024 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 300 PLUS INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since February 2003.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.